Anticancer Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Nov 2019| FMR554A| Fact Market Research

Report Highlights

Anticancer Drugs Market - Scope of the Study

Fact.MR, in its exclusive research report on the anticancer drugs market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the anticancer drugs market during the forecast period (2020 - 2025). With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the anticancer drugs market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the anticancer drugs market. The study also recalibrates the impact of each of these dynamics to estimate the size of the anticancer drugs market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that hold potential to influence the growth of the anticancer drugs market during the forecast period.

The global study on the anticancer drugs market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the anticancer drugs landscape. In addition, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the anticancer drugs market.

The global study offers crucial information about global, regional, and local players operating in the anticancer drugs market, along with their estimated market share. The market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players, the study also aims at equipping stakeholders with the best of information regarding the winning strategies, recent developments, and financials.

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the global anticancer drugs market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the anticancer drugs market.

A list of leading, prominent, and emerging players operating in the global anticancer drugs market is included in this comprehensive study, which consists of F.Hoffmann-La Roche Ltd, Novartis AG, Eli Lily and Company, Amgen Inc., Pfizer Inc., CELGENE CORPORATION, Bayer AG, Merck & Co., Inc., AstraZeneca, and Takeda Pharmaceutical Company Limited.

Anticancer Drugs Market - Research Methodology

The research undertaken by seasoned analysts at Fact.MR consists of a systematic approach, including both, the primary and secondary research methodology. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors. Besides these, respondents also include CEOs, Presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the anticancer drugs market.

In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as the Stock analyst websites, such as Seeking Alpha, Growth Financial, Yahoo Finance, and others were studied.

Besides this, governmental and public portals, such as World Health Organizations (WHO), FDA websites, Clinicaltrials.gov (U.S.), European Medicines Agency (EMA), Centres for Disease Control and Prevention (CDC), American Cancer Society, and National Health Services (NHS), were referred to, to gain crucial information regarding key players in the anticancer drugs market. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

  • Table 1 : Pipeline Analysis, by Phase III
  • Table 2 : Pipeline Analysis, By Phase II and Phase I
  • Table 3 : Pipeline Analysis, By Preclinical Trial (1/2)
  • Table 4 : Pipeline Analysis, By Preclinical Trial (2/2)
  • Table 5 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 6 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs, 2015–2025
  • Table 7 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Targeted Drugs, 2015–2025
  • Table 8 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type, 2015–2025
  • Table 9 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, by Therapy Type, 2015–2025
  • Table 10 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 11 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 12 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 13 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type-Targeted Drugs , 2015–2025
  • Table 14 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 15 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 16 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 17 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 18 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 19 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type-Targeted Drugs , 2015–2025
  • Table 20 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 21 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 22 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 23 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 24 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 25 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type-Targeted Drugs , 2015–2025
  • Table 26 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 27 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 28 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 29 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 30 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 31 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type-Targeted Drugs , 2015–2025
  • Table 32 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 33 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 34 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 35 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 36 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 37 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type-Targeted Drugs , 2015–2025
  • Table 38 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 39 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 40 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Figure 1 : Global Anticancer Drugs Market, by Drug Type, Market Size (US$ Mn), 2016 (A)
  • Figure 2 : Global Anticancer Drugs Market Revenue (%), by Cancer Therapy, 2016 (A)
  • Figure 3 : Global Anticancer Drugs Market Revenue (%), by Region, 2016 (A)
  • Figure 4 : Opportunity Map, By Drug Type 2016
  • Figure 5 : Opportunity Map, By Therapy type and Cancer Type 2016
  • Figure 6 : Global Anticancer Drugs Market - Key Industry Developments
  • Figure 7 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 8 : Porter’s Five Forces Analysis
  • Figure 9 : Global Anticancer Drugs Market - Value Chain Analysis
  • Figure 10 : Market Value Share, by Drug Type (2016)
  • Figure 11 : Market Value Share, by Therapy Type (2016)
  • Figure 12 : Market Value Share, by Cancer Types (2016)
  • Figure 13 : Global Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 14 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cytotoxic Drugs, 2015–2025
  • Figure 15 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Drugs, 2015–2025
  • Figure 16 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hormonal Drugs, 2015–2025
  • Figure 17 : Global Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 18 : Global Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 19 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemotherapy, 2015–2025
  • Figure 20 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Therapy, 2015–2025
  • Figure 21 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunotherapy, 2015–2025
  • Figure 22 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunotherapy, 2015–2025
  • Figure 23 : Global Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 24 : Global Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 25 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2015–2025
  • Figure 26 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2015–2025
  • Figure 27 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Leukemia, 2015–2025
  • Figure 28 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2015–2025
  • Figure 29 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 30 : Global Anticancer Drugs Market Attractiveness Analysis, by Cancer Type, 2017–2025
  • Figure 31 : Global Scenario of Anticancer Drugs Market
  • Figure 32 : Global Anticancer Drugs Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 33 : Global Anticancer Drugs Market Attractiveness Analysis, by Region
  • Figure 34 : North America Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 35 : North America Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 36 : North America Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 37 : North America Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 38 : North America Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 39 : North America Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 40 : North America Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 41 : North America Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 42 : North America Market Attractiveness Analysis, by Country
  • Figure 43 : Europe Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 44 : Europe Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 45 : Europe Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 46 : Europe Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 47 : Europe Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 48 : Europe Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 49 : Europe Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 50 : Europe Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 51 : Europe Market Attractiveness Analysis, by Country
  • Figure 52 : Asia Pacific Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 53 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 54 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 55 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 56 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 57 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 58 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 59 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 60 : Asia Pacific Market Attractiveness Analysis, by Country
  • Figure 61 : Latin America Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 62 : Latin America Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 63 : Latin America Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 64 : Latin America Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 65 : Latin America Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 66 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 67 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 68 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 69 : Latin America Market Attractiveness Analysis, by Country
  • Figure 70 : Middle East & Africa Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 71 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 72 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 73 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 74 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 75 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 76 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 77 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 78 : Middle East & Africa Market Attractiveness Analysis, by Country
  • Figure 79 : Global Anticancer Drugs Market Share Analysis, by Company (2016)

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report